Production (Stage)
Sharp Therapeutics Corp.
SHRXF
$1.29
$0.000.00%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -42.13% | 0.00% | 1,389.82% | -37.94% | 0.00% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 286.30% | 0.00% | -15.31% | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -38.93% | 0.00% | 1,057.95% | -- | -- |
|
|||||
Total Current Assets | -38.93% | 0.00% | 1,057.95% | -- | -- |
Net Property, Plant & Equipment | -2.64% | 0.00% | -4.66% | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | -- | -- |
Total Assets | -30.67% | 0.00% | 227.93% | -- | -- |
|
|||||
Total Accounts Payable | 35.15% | 0.00% | -36.95% | -- | -- |
Total Accrued Expenses | -59.61% | 0.00% | -41.19% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 16.02% | 0.00% | 16.77% | -- | -- |
Total Finance Division Other Current Liabilities | 1,463.43% | 0.00% | 692.12% | -- | -- |
Total Other Current Liabilities | 1,463.43% | 0.00% | 692.12% | -- | -- |
Total Current Liabilities | 270.27% | 0.00% | -95.28% | -- | -- |
|
|||||
Total Current Liabilities | 270.27% | 0.00% | -95.28% | -- | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -1.08% | 0.00% | -1.55% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 93.97% | 0.00% | -87.62% | -- | -- |
|
|||||
Common Stock & APIC | 0.15% | 0.00% | 336.44% | -- | -- |
Retained Earnings | -16.37% | 0.00% | -1.15% | -- | -- |
Treasury Stock & Other | -426.23% | 0.00% | -- | -- | -- |
Total Common Equity | -125.64% | 0.00% | 117.81% | -26.39% | 0.00% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -125.64% | 0.00% | 117.81% | -26.39% | 0.00% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -125.64% | 0.00% | 117.81% | -26.39% | 0.00% |
|